Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Immuno-Biological Laboratories Co Ltd Lowers Consolidated Full-year Forecast for FY 2014

Monday, 21 Oct 2013 03:00am EDT 

Immuno-Biological Laboratories Co Ltd announced that it has lowered the consolidated full-year forecast for revenue from JPY 1,000 million to JPY 720 million, operating profit (loss) from JPY (100 million) to JPY (200 million), ordinary profit (loss) from JPY (105 million) to JPY (205 million), net profit (loss) from JPY (115 million) to JPY (225 million) and earning (loss) per share from JPY (18.55) to JPY (36.09) for the fiscal year ending March 31, 2014. The Company lowered the consolidated full-year outlook due to decreased sales. 

Company Quote

-7.0 -0.64%
19 Dec 2014